Parnax Lab Ltd
BSE : 506128
NSE :
Sector :Health care
ISIN Code : INE383L01019
NSE
Not ListedBSE
117.60
-1.40 (-1.18%)
Board Meeting Intimation for Approval Of Unaudited Stand-Alone And Consolidated Financial Results For The Quarter And Three Months Ended June 30 2023.
12:15 PM,9th Oct 2024
PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q1) and three months ended 30th June 2023 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015.2. To decide the date of the Annual General Meeting of the Company for the Financial Yearended 31st March 2023;3. Any other business with the permission of the Chair.Kindly note that the approved results will be sent to you after the conclusion of the Board meeting.
